5-MeO-DMT
This article needs additional citations for verification. (August 2007) (Learn how and when to remove this template message) |
File:5-MeO-DMT.png | |
File:5-MeO-DMT-3d-sticks.png | |
Clinical data | |
---|---|
Routes of administration | Smoked, Insufflated |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C13H18N2O |
Molar mass | 218.298 g/mol |
3D model (JSmol) | |
|
5-MeO-DMT is a very powerful psychedelic tryptamine. It is found in a wide variety of plant and toad species, and like its close relatives DMT and bufotenin (5-OH-DMT), it has been used as an entheogen by South American shamans for thousands of years. 5-MeO-DMT is sometimes referred to as "Businessman's Trip" due to its short duration.[citation needed]
Chemistry
5-MeO-DMT was first synthesized in 1936, and in 1959 it was isolated as one of the psychoactive ingredients of Anadenanthera peregrina seeds used in preparing Yopo snuff. It was once believed to be a major player in the psychoactive effects of the snuff. However, recent tests confirm that bufotenin is the main active psychoactive ingredient of Yopo and that DMT and 5-MeO-DMT are present in quantities too small to elicit much effects.[1] It occurs in many organisms that contain bufotenin(e) (5-hydroxy-DMT), and is the O-methyl analogue of that compound.
History
Traditionally 5-MeO-DMT has been used in psychedelic snuff made from Virola bark resin, and may be a trace constituent of ayahuasca when plants such as Diplopterys cabrerana are used as an admixture. 5-MeO-DMT is also found in the venom of the Colorado River Toad (Bufo alvarius), although there is no direct evidence this was used as a hallucinogen until recent times.
Use and effects
When used as a drug in its purified form, 5-MeO-DMT is smoked, insufflated, or injected and is active at a dose of as little as 2 mg. 5-MeO-DMT is also active orally, when taken with an monoamine oxidase inhibitor, but according to numerous reports, the combination with MAOI is extremely unpleasant and has a strong body-load. According to the researcher Jonathan Ott, 5-MeO-DMT is active orally with doses over 30 mg without aid of a MAOI.
The onset of effects occurs in seconds after smoking/injecting, or minutes after insufflating, and the experience is sometimes described as similar to a near-death experience. Peak effects last for approximately 5-10 minutes, when smoked. When insufflated, the peak effects are considerably less intense, but last for 15-25 minutes on average.
Although similar in many respects to its close relatives DMT and bufotenin (5-OH-DMT), the effects are typically not as visual. Some users report experiencing no visual effects from it even at very high doses.[2]
Some report the effects to be unpleasant causing nausea and the feeling of being "sat on by an elephant".[3]
Erowid lists the following effects for smoked 5-MeO-DMT:[2]
Positive
- immersive experiences
- powerful "rushing" sensation
- radical perspective shifting
- profound life-changing spiritual experiences
- some people experience erotic / sensual enhancement
- occasional euphoria
- internal visions (actual visual effects not as common)
- journey into mind
Neutral
- short duration
- change in perception of time
- experience of "the void"
- lack of memory of experience
- muscle jerking, twitching, abnormal vocalizations
- unconsciousness / nonresponsiveness lasting 5-20 minutes
- dissociation
Negative
- overly-intense experiences
- nausea[3]
- sense of pressure in the body[3]
- hard on the lungs to smoke
- difficulty integrating experiences
- fear, terror and panic
- dysphoria (bad feelings)
- fast onset and intensity can lead to problems if not prepared (dropped pipe, knocking things over, falling & hitting head, etc)
Legality
International Law
Denmark
As of December 1, 2004, 5-MeO-DMT is legally restricted to "medical or scientific purposes". See EMCDDA. (Thanks Vman and Ali)
Germany
Schedule I / Highest level of control, unable to be prescribed, manufactured, or possessed as of Sep, 1999. (listed as [2-(5-Methoxyindol-3-yl)ethyl]dimethylazan) (see Deutsche BtMG or http://www.silicium-sensei.de/projecte/drugs/news/news.html)
Greece
5-MeO-DMT became a controlled substance in Greece on Feb 18, 2003 [EU Legal Database].
New Zealand
5-MeO-DMT is Schedule I (Class A) in New Zealand.
Sweden
Controlled in Sweden as of Oct 1, 2004 (see notisum.se)
Switzerland
5-MeO-DMT is Schedule I in Switzerland. [unconfirmed]
US State Law
Nebraska
Schedule I (Reference)
S. Dakota
Schedule I : 5-methoxy-N, N-Dimethyltryptamine. Feb 2003
See also
External links
References
- ↑ Pharmanopo-Psychonautics: Human Intranasal, Sublingual, Intrarectal, Pulmonary and Oral Pharmacology of Bufotenine by Jonathan Ott, The Journal of Psychoactive Drugs, September 2001
- ↑ 2.0 2.1 Erowid. "Effects".
- ↑ 3.0 3.1 3.2 Psychecelic Chemistry by Michael Valentine Smith, Page 40, ISBN 0915179105
Template:TiHKAL Template:Hallucinogenic tryptamines Template:Tryptamines fi:5-MeO-DMT
- Pages with script errors
- Pages with reference errors
- Articles needing additional references from August 2007
- Articles with invalid date parameter in template
- All articles needing additional references
- Pages with broken file links
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Articles containing unverified chemical infoboxes
- All articles with unsourced statements
- Articles with unsourced statements from June 2007
- Psychedelic tryptamines
- Ayahuasca
- Natural tryptamine alkaloids